Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease

Journal of Neurochemistry

Volumn 93, Issue 6, 2005, Pages 1361-1370

  Brustovetsky, N ^a,b   LaFrance, R ^a   Purl, K J ^a   Brustovetsky, T ^a   Keene, C D ^a   Low, W C ^a   Dubinsky, Janet M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CAG repeat diseases; Differential susceptibility; Excitotoxicity; Permeability transition; Regional brain mitochondria

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CYCLOPHILIN; CYCLOPHILIN D; CYCLOSPORIN A; HUNTINGTIN; MITOCHONDRIAL PROTEIN; POLYGLUTAMINE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; GENE MUTATION; GENE OVEREXPRESSION; HUNTINGTON CHOREA; MEMBRANE DEPOLARIZATION; MEMBRANE MODEL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGING; ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL DEATH; CELL MEMBRANE PERMEABILITY; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; HUNTINGTON DISEASE; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 20744433946     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03036.x     Document Type: Article

References (35)

1. Anderson M. F. and Sims N. R. (1999) Mitochondrial respiratory function and cell death in focal cerebral ischemia. J. Neurochem. 73, 1189-1199.
2. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 12, 248-254.
3. Brouillet E., Hantraye P., Fenante R. J., Dolan R., Leroy-Willig A., Kowall N. W. and Beal M. F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl Acad. Sci. 92, 7105-7109.
4. Brustovetsky N. and Dubinsky J. M. (2000) Dual responses of CNS mitochondria to elevated calcium. J. Neurosci. 20, 103-113.
5. Brustovetsky N., Brustovetsky T., Jemmerson R. and Dubinsky J. M. (2002) Calcium-induced Cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J. Neurochem. 80, 207-218.
6. Brustovetsky N., Brustovetsky T., Purl K. J., Capano M., Crompton M. and Dubinsky J. M. (2003) Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 23, 4858-4867.
7. Budd S. L., Termed L., Lishnak T. and Lipton S. A. (2000) Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl Acad. Sci. USA 97, 6161-6166.
8. Cha J. H., Frey A. S., Alsdorf S. A., Kerner J. A., Kosinski C. M., Mangiarini L., Penney J. B. J., Davies S. W., Bates G. P. and Young A. B. (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 981-989.
9. Choo Y. S., Johnson G. V., MacDonald M., Detloff P. J. and Lesort M. (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407-1420.
10. Crompton M. (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341, 233-249.
11. Crompton M., Virji S. and Ward J. M. (1998) Cyclophilin-D binds strongly to complexes of the voltage-dependant anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258, 729-735.
12. Dubinsky J. M. and Levi Y. (1998) Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons. J. Neurosci. Res. 53, 728-741.
13. Fossale E., Wheeler V. C., Vrbanac V., Lebel L. A., Teed A., Mysore J. S., Gusella J. F., MacDonald M. E. and Persichetti F. (2002) Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice. Hum. Mol. Genet. 11, 2233-2241.
14. Friberg H., Connern C., Halestrap A. P. and Wieloch T. (1999) Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J. Neurochem. 72, 2488-2497.
15. Graveland G. A., Williams R. S. and Difiglia M. (1985) Evidence for degenerative and regenerative changes in neostiatal spiny neurons in Huntington's disease. Science 227, 770-773.
16. Hansson O., Guatteo E., Mercuri N. B., Bernardi G., Li X. J., Castilho R. F. and Brundin P. (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J. Neurosci. 14, 1492-1504.
17. Inman D., Guth L. and Steward O. (2002) Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains, of mice. J. Comp Neurol. 451, 225-235.
18. Klohn P. C., Soriano M. E., Irwin W., Penzo D., Scorrano L., Bitsch A., Neumann H. G. and Bemardi P. (2003) Early resistance to cell death and to onset of the mitochondrial permeability transition during hepatocarcinogenesis with 2-acetylaminofluorene. Proc. Natl Acad. Sci. USA 100, 10 014-10 019.
19. Li S. H., Yu Z. X., Li C. L., Nguyen H. P., Zhou Y. X., Deng C. and Li X. J. (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci. 23, 6956-6964.
20. Lievens J. C., Woodman B., Mahal A., Spasic-Boscovic O., Samuel D., Kerkerian-Le G. L. and Bates G. P. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis. 8, 807-821.
21. Lifshitz J., Friberg H., Neumar R. W., Raghupathi R., Welsh F. A., Janmey P., Saatman K. E., Wieloch T., Grady M. S. and McIntosh T. K. (2003) Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J. Cereb. Blood Flow Metab. 23, 219-231.
22. Mangiarini L., Sathasivam K., Seller M., Cozens E., Harper A., Hetherington Lawton M., Trottier Y., Lehrach H., Davies S. W. and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
23. Panov A. V., Gutekunst C. A., Levitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J. and Greenamyre J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nature Neuroscience 5, 731-736.
24. Ross C. A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819-822.
25. Sawa A., Wiegand G. W., Cooper J., Margolis R. L., Sharp A. H., Lawler J. F. J., Greenamyre J. T., Snyder S. H. and Ross C. A. (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondial depolarization. Nat Med. 5, 1194-1198.
26. Schauwecker P. E. and Steward O. (1997) Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl Acad. Sci. U S A 94, 4103-4108.
27. Snider B. J., Moss J. L., Revilla F. J., Lee C., Wheeler V. C., MacDonald M. E. and Choi D. W. (2003) Neocortical neurons cultured from mice with expanded cag repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults. Neurosci. 120, 617-625.
28. Warner J. P., Barren L. H. and Brock D. J. (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol. Cell Probes 1, 235-239.
29. Wheeler V. C., Auerbach W., White J. K. et al. (1999) Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 8, 115-122.
30. Wheeler V. C., White J. K., Gutekunst C. A. et al. (200Oa) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9, 503-513.
31. Wheeler V. C., White J. K., Gutekunst C. A. et al. (2000b) Long glutamine tracts cause nuclear localization of a novel form of huntingtin inmedium spiny striatal neurons in HdhQ92 and HdhQ 111 knock-in-mice. Human Mol Genet 9, 503-513.
32. Wheeler V. C., Gutekunst C. A., Vrbanac V. et al. (2002) Early pheno types that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum. Mol. Genet. 11, 633-640.
33. Zaidan E., Sheu K. F. and Sims N. R. (1998) The pyravate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J. Neurochem. 70, 233-241.
34. Zaidan E., Nilsson M. and Sims N. R. (1999) Cyclosporin A-sensitive changes in mitochondrial glutathione are an early response to intrastiatal NMDA or forebrain ischemia in rats. J. Neurochem. 73, 2214-2217.
35. Zeron M. M., Haussen O., Chen N., Wellington C. L., Leavitt B. R., Brundin P., Hayden M. R. and Raymond L. A. (2002) Increased sensitivity to N-methyl-D-aspartate receptormediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860.